Continuous fall in hemoglobin level is a poor prognostic factor in patients with nasopharyngeal carcinoma treated with radiotherapy

Chinese Journal of Cancer

Volumn 29, Issue 5, 2010, Pages 561-566

  Gao, Jin ^a   Hu, Jing Ye ^a   Xia, Yun Fei ^a   Yi, Wei ^a   Tao, Ya Lan ^a   Li, Guo ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Hemoglobin; Nasopharyngeal neoplasm; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OUTCOME ASSESSMENT; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

EID: 79955838536     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10533     Document Type: Article

References (22)

1. Semenza GL. Intratumoral hypoxia, radiation resistance, and HIF-1 [J]. Cancer Cell, 2004, 5(5): 405-406.
2. Rades D, Stoehr M, Kazic N, et al. Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy [J]. Int J Radiat Oncol Biol Phys, 2008, 70(4): 1108-1114.
3. Schafer U, Micke O, Muller SB, et al. Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors [J]. Strahlenther Onkol, 2003, 179(8): 527-534.
4. Choi YS, Yi CM, Sin JI, et al. Impact of hemoglobin on survival of cervical carcinoma patients treated with concurrent chemoradiotherapy is dependent on lymph node metastasis findings by magnetic resonance imaging [J]. Int J Gynecol Cancer, 2006, 16(5): 1846-1854.
5. Metindir J, Bilir Dilek G. Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma [J]. J Cancer Res Clin Oncol, 2009, 135(1): 125-129.
6. Cho EI, Sasaki CT, Haffty BG. Prognostic significance of pretreatment hemoglobin for local control and overall survival in T1-T2N0 larynx cancer treated with external beam radiotherapy [J]. Int J Radiat Oncol Biol Phys, 2004, 8(4): 1135-1140.
7. Munstedt K, Volzing M, Von Georgi R. Hemoglobin levels during radiotherapy and their influence on local control and survival of patients with endometrial carcinoma [J]. Oncol Rep, 2004, 11(3): 711-717.
8. Tarnawski R, Skladowski K, Maciejewski B. Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx [J]. Int J Radiat Oncol Biol Phys, 1997, 38(5): 1007-1011.
9. Chua DT, Sham JS, Choy DT. Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone [J]. Cancer, 2004, 101(2): 307-316.
10. Rutkowski T, Suwinski R, Idasiak A. The prognostic value of hemoglobin concentration in postoperative radiotherapy of 835 patients with laryngeal cancer [J]. Int J Radiat Oncol Biol Phys, 2007, 69(4): 1018-1023.
11. Nordsmark M, Overgaard J. Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer [J]. Acta Oncol, 2004, 43(4): 396-403.
12. Kinoshita M, Johnson DL, Shatney CH, et al. Cancer cells surviving hypoxia obtain hypoxia resistance and maintain anti-apoptotic potential under reoxygenation [J]. Int J Cancer, 2001, 91(3): 322-326.
13. Vaupel P, Mayer A. Hypoxia and anemia: effects on tumor biology and treatment resistance [J]. Transfus Clin Biol, 2005, 12(1): 5-10.
14. Evans SM, Koch CJ. Prognostic significance of tumor oxygenation in humans[J]. Cancer Lett, 2003, 195(1): 1-16.
15. Xia YF, Qian JY, Zhang EP. Practical radiotherapy for nasopharyngeal carcinoma [M]. Beijing: PeKing University Medical Press, 2003: 399. [in Chinese]
16. Rudat V, Stadler P, Becker A, et al. Predictive value of the tumor oxygenation by means of pO2 histography in patients with advanced head and neck cancer [J]. Strahlenther Onkol, 2001, 177(9): 462-468.
17. Koshiji M, Kageyama Y, Pete EA, et al. HIF-Ia induces cell cycle arrest by functionally counteracting Myc [J]. EMBO J, 2004, 23(9): 1949-1956.
18. Madjdpour C, Spahn DR. Allogenic red blood transfusions: efficacy, risks, alternatives and indications [J]. Br J Anaesth, 2005, 95(1): 33-42.
19. Glaser CM, Millesi W, Kornek GV, et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx [J]. Int J Radiat Oncol Biol Phys, 2001, 50(3): 705-715.
20. Rades D, Tribius S, Yekebas EF, et al. Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study [J]. Int J Radiat Oncol Biol Phys, 2006, 65(2): 459-465.
21. Charu V, Belani C, Gill AN, et al. Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: A controlled, randomized, open-label phase 2 trial [J]. Oncologist, 2007, 12(6): 727-737.
22. Smith RE Jr, Aapro MS, Ludwig H, et al. Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study [J]. J Clin Oncol, 2008, 26(7): 1040-1050.